Showing results (1131-1140 of 10,077) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|October 25, 2014
Oxidative stress and antioxidants in carcinogenesis and integrative therapy of cancerLidija Milkovic, Werner Siems, Renate Siems, et al.Current Pharmaceutical Design|October 25, 2014
Attacking c-Myc: targeted and combined therapies for cancerHuilin Huang, Hengyou Weng, Hui Zhou, et al.Current Pharmaceutical Design|October 25, 2014
The exploitation of Toll-like receptor 3 signaling in cancer therapyTanja Matijevic Glavan, Jasminka PavelicCurrent Pharmaceutical Design|October 25, 2014
Curcumin in combined cancer therapyKoraljka Gall Troselj, Renata Novak KujundzicCurrent Pharmaceutical Design|October 30, 2014
Nano-sized platforms for vaginal drug deliveryMazen M El-Hammadi, Jose L AriasCurrent Pharmaceutical Design|October 30, 2014
Chemistry, physiology, and pharmacology of β-adrenergic mechanisms in the heart. Why are β-blocker antiarrhythmics superior?A József Szentmiklosi, Norbert Szentandrássy, Bence Hegyi, et al.Current Pharmaceutical Design|October 30, 2014
ATP-sensitive potassium channel modulators and cardiac arrhythmias: an updateDanina M Muntean, Loránd Kiss, Norbert Jost, et al.Current Pharmaceutical Design|October 30, 2014
The Janus face of adenosine: antiarrhythmic and proarrhythmic actionsA József Szentmiklosi, Zoltán Galajda, Ágnes Cseppento, et al.Current Pharmaceutical Design|November 20, 2013
New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeuticsE Jeffrey North, Mary Jackson, Richard E LeeCurrent Pharmaceutical Design|November 20, 2013
DprE1--from the discovery to the promising tuberculosis drug targetKatarína Mikusová, Vadim Makarov, João NeresPageof 1,008